1887

Chapter 1 : Evolution of Bacterial Pathogens Within the Human Host

Authors: Kimberly A. Bliven1, Anthony T. Maurelli2
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814; 2: Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814
Content Type: Monograph
Publication Year: 2016
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Evolution of Bacterial Pathogens Within the Human Host, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819286/9781555819279_Chap01-1.gif /docserver/preview/fulltext/10.1128/9781555819286/9781555819279_Chap01-2.gif

Abstract:

The success or failure of a pathogen is entirely dependent on its ability to survive, reproduce, and spread to a new host or environment. Host immune systems, predators, microbial competitors, parasites, and environmental resource limitations all exert selective pressures that shape the genomes of microbial populations ( ). Host fitness, meanwhile, is determined by the ability of the host to survive and reproduce; the host must therefore effectively curtail diseases that impair either of these abilities.

Citation: Bliven K, Maurelli A. 2016. Evolution of Bacterial Pathogens Within the Human Host, p 3-13. In Kudva I, Cornick N, Plummer P, Zhang Q, Nicholson T, Bannantine J, Bellaire B (ed),

Virulence Mechanisms of Bacterial Pathogens, Fifth Edition

. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.VMBF-0017-2015
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555819286.chap1
1. Toft C,, Andersson SG . 2010. Evolutionary microbial genomics: insights into bacterial host adaptation. Nat Rev Genet 11 : 465– 475.[PubMed] [CrossRef]
2. Dawkins R,, Krebs JR . 1979. Arms races between and within species. Proc R Soc London B Biol Sci 205 : 489– 511.[PubMed] [CrossRef]
3. Woolhouse ME,, Webster JP,, Domingo E,, Charlesworth B,, Levin BR . 2002. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet 32 : 569– 577.[PubMed] [CrossRef]
4. Taubenberger JK,, Kash JC . 2010. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7 : 440– 551.[PubMed] [CrossRef]
5. Mideo N . 2009. Parasite adaptations to within-host competition. Trends Parasitol 25 : 261– 268.[PubMed] [CrossRef]
6. Cooney NM,, Klein BS . 2008. Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol 11 : 511– 516.[PubMed] [CrossRef]
7. Williams GC . 1957. Pleiotropy, natural selection, and the evolution of senescence. Evolution 11 : 398– 411.[CrossRef]
8. Salazar-Gonzalez RM,, Srinivasan A,, Griffin A,, Muralimohan G,, Ertelt JM,, Ravindran R,, Vella AT,, McSorley SJ . 2007. Salmonella flagellin induces bystander activation of splenic dendritic cells and hinders bacterial replication in vivo . J Immunol 179 : 6169– 6175.[PubMed] [CrossRef]
9. Wu W,, Badrane H,, Arora S,, Baker HV,, Jin S . 2004. MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa . J Bacteriol 186 : 7575– 7585.[PubMed] [CrossRef]
10. Boucher JC,, Yu H,, Mudd MH,, Deretic V . 1997. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65 : 3838– 3846.[PubMed]
11. Hauser AR . 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7 : 654– 665.[PubMed] [CrossRef]
12. Schulz zur Wiesch P,, Engelstadter J,, Bonhoeffer S . 2010. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother 54 : 2085– 2095.[PubMed] [CrossRef]
13. Morgan AD,, Koskella B, . 2011. Coevolution of host and pathogen, p 147– 171. In Tibayreng M (ed), Genetics and Evolution of Infectious Diseases. Elsevier, Burlington, MA. [CrossRef]
14. Langridge GC,, Fookes M,, Connor TR,, Feltwell T,, Feasey N,, Parsons BN,, Seth-Smith HM,, Barquist L,, Stedman A,, Humphrey T,, Wigley P,, Peters SE,, Maskell DJ,, Corander J,, Chabalgoity JA,, Barrow P,, Parkhill J,, Dougan G,, Thomson NR . 2015. Patterns of genome evolution that have accompanied host adaptation in Salmonella . Proc Natl Acad Sci USA 112 : 863– 868.[PubMed] [CrossRef]
15. Kemen AC,, Agler MT,, Kemen E . 2015. Host-microbe and microbe-microbe interactions in the evolution of obligate plant parasitism. New Phytol 206 : 1207– 1228.[PubMed] [CrossRef]
16. Price CT,, Richards AM,, Von Dwingelo JE,, Samara HA,, Abu Kwaik Y . 2014. Amoeba host- Legionella synchronization of amino acid auxotrophy and its role in bacterial adaptation and pathogenic evolution. Environ Microbiol 16 : 350– 358.[PubMed] [CrossRef]
17. Davies J,, Davies D . 2010. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74 : 417– 433.[PubMed] [CrossRef]
18. Wiedenbeck J,, Cohan FM . 2011. Origins of bacterial diversity through horizontal genetic transfer and adaptation to new ecological niches. FEMS Microbiol Rev 35 : 957– 976.[PubMed] [CrossRef]
19. Houchhut B,, Dobrindt U,, Hacker J, . 2006. The contribution of pathogenicity islands to the evolution of bacterial pathogens, p 83– 107. In Seifert HS,, DiRita V (ed), The Evolution of Microbial Pathogens. ASM Press, Washington, DC. [CrossRef]
20. Whitman WB,, Coleman DC,, Wiebe WJ . 1998. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 95 : 6578– 6583.[PubMed] [CrossRef]
21. Doran KS,, Banerjee A,, Disson O,, Lecuit M . 2013. Concepts and mechanisms: crossing host barriers. Cold Spring Harbor Perspect Med 3 : a010090. doi:10.1101/cshperspect.a010090 [PubMed] [CrossRef]
22. Tsukita S,, Yamazaki Y,, Katsuno T,, Tamura A,, Tsukita S . 2008. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27 : 6930– 6938.[PubMed] [CrossRef]
23. McGuckin MA,, Linden SK,, Sutton P,, Florin TH . 2011. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9 : 265– 278.[PubMed] [CrossRef]
24. Linden SK,, Sutton P,, Karlsson NG,, Korolik V,, McGuckin MA . 2008. Mucins in the mucosal barrier to infection. Mucosal Immunol 1 : 183– 197.[PubMed] [CrossRef]
25. Gutierrez-Jimenez J,, Arciniega I,, Navarro-Garcia F . 2008. The serine protease motif of Pic mediates a dose-dependent mucolytic activity after binding to sugar constituents of the mucin substrate. Microb Pathog 45 : 115– 123.[PubMed] [CrossRef]
26. Henderson IR,, Czeczulin J,, Eslava C,, Noriega F,, Nataro JP . 1999. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli . Infect Immun 67 : 5587– 5596.[PubMed]
27. Sonnenburg JL,, Xu J,, Leip DD,, Chen CH,, Westover BP,, Weatherford J,, Buhler JD,, Gordon JI . 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307 : 1955– 1959.[PubMed] [CrossRef]
28. Rasko DA,, Rosovitz MJ,, Myers GS,, Mongodin EF,, Fricke WF,, Gajer P,, Crabtree J,, Sebaihia M,, Thomson NR,, Chaudhuri R,, Henderson IR,, Sperandio V,, Ravel J . 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 190 : 6881– 6893.[PubMed] [CrossRef]
29. Jones B,, Pascopella L,, Falkow S . 1995. Entry of microbes into the host: using M cells to break the mucosal barrier. Curr Opin Immunol 7 : 474– 478.[PubMed] [CrossRef]
30. Wu S,, Lim KC,, Huang J,, Saidi RF,, Sears CL . 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci USA 95 : 14979– 14984.[PubMed] [CrossRef]
31. Hanakawa Y,, Schechter NM,, Lin C,, Garza L,, Li H,, Yamaguchi T,, Fudaba Y,, Nishifuji K,, Sugai M,, Amagai M,, Stanley JR . 2002. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 110 : 53– 60.[PubMed] [CrossRef]
32. Franco AA,, Cheng RK,, Chung GT,, Wu S,, Oh HB,, Sears CL . 1999. Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J Bacteriol 181 : 6623– 6633.[PubMed]
33. Yamaguchi T,, Nishifuji K,, Sasaki M,, Fudaba Y,, Aepfelbacher M,, Takata T,, Ohara M,, Komatsuzawa H,, Amagai M,, Sugai M . 2002. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun 70 : 5835– 5845.[PubMed] [CrossRef]
34. Jackson MP,, Iandolo JJ . 1986. Cloning and expression of the exfoliative toxin B gene from Staphylococcus aureus . J Bacteriol 166 : 574– 580.[PubMed]
35. Jensen VB,, Harty JT,, Jones BD . Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer’s patches. Infect Immun 66 : 3758– 3766.[PubMed]
36. McGuckin MA,, Every AL,, Skene CD,, Linden SK,, Chionh YT,, Swierczak A,, McAuley J,, Harbour S,, Kaparakis M,, Ferrero R,, Sutton P . 2007. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 133 : 1210– 1218.[PubMed] [CrossRef]
37. Vinall LE,, King M,, Novelli M,, Green CA,, Daniels G,, Hilkens J,, Sarner M,, Swallow DM . 2002. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 123 : 41– 49.[PubMed] [CrossRef]
38. Costa NR,, Mendes N,, Marcos NT,, Reis CA,, Caffrey T,, Hollingsworth MA,, Santos-Silva F . 2008. Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells. World J Gastroenterol 14 : 1411– 1414.[PubMed] [CrossRef]
39. Vos HL,, de Vries Y,, Hilkens J . 1991. The mouse episialin (Muc1) gene and its promoter: rapid evolution of the repetitive domain in the protein. Biochem Biophys Res Commun 181 : 121– 130.[PubMed] [CrossRef]
40. Lambris JD,, Ricklin D,, Geisbrecht BV . 2008. Complement evasion by human pathogens. Nat Rev Microbiol 6 : 132– 142.[PubMed] [CrossRef]
41. Rooijakkers SH,, Ruyken M,, Roos A,, Daha MR,, Presanis JS,, Sim RB,, van Wamel WJ,, van Kessel KP,, van Strijp JA . 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nature Immunol 6 : 920– 927.[PubMed] [CrossRef]
42. Rooijakkers SH,, van Wamel WJ,, Ruyken M,, van Kessel KP,, van Strijp JA . 2005. Anti-opsonic properties of staphylokinase. Microbes Infect 7 : 476– 484.[PubMed] [CrossRef]
43. Del Tordello E,, Vacca I,, Ram S,, Rappuoli R,, Serruto D . 2014. Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum. Proc Natl Acad Sci USA 111 : 427– 432.[PubMed] [CrossRef]
44. Skaar EP . 2010. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 6 : e1000949. [PubMed] [CrossRef]
45. Rogers HJ . 1973. Iron-binding catechols and virulence in Escherichia coli . Infect Immun 7 : 445– 456.[PubMed]
46. Goetz DH,, Holmes MA,, Borregaard N,, Bluhm ME,, Raymond KN,, Strong RK . 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10 : 1033– 1043.[PubMed] [CrossRef]
47. Fischbach MA,, Lin H,, Zhou L,, Yu Y,, Abergel RJ,, Liu DR,, Raymond KN,, Wanner BL,, Strong RK,, Walsh CT,, Aderem A,, Smith KD . 2006. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 103 : 16502– 16507.[PubMed] [CrossRef]
48. Hornef MW,, Wick MJ,, Rhen M,, Normark S . 2002. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol. 3 : 1033– 1040.[PubMed] [CrossRef]
49. Gebert B,, Fischer W,, Weiss E,, Hoffmann R,, Haas R . 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301 : 1099– 1102.[PubMed] [CrossRef]
50. Nothelfer K,, Arena ET,, Pinaud L,, Neunlist M,, Mozeleski B,, Belotserkovsky I,, Parsot C,, Dinadayala P,, Burger-Kentischer A,, Raqib R,, Sansonetti PJ,, Phalipon A . 2014. B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection. J Exp Med 211 : 1215– 1229.[PubMed] [CrossRef]
51. Blair JM,, Webber MA,, Baylay AJ,, Ogbolu DO,, Piddock LJ . 2015. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13 : 42– 51.[PubMed] [CrossRef]
52. Andersen JL,, He GX,, Kakarla P,, K CR,, Kumar S,, Lakra WS,, Mukherjee MM,, Ranaweera I,, Shrestha U,, Tran T,, Varela MF . 2015. Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health 12 : 1487– 1547.[PubMed] [CrossRef]
53. Wilson DN,, Schluenzen F,, Harms JM,, Starosta AL,, Connell SR,, Fucini P . 2008. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc Natl Acad Sci USA 105 : 13339– 13344.[PubMed] [CrossRef]
54. Feng J,, Lupien A,, Gingras H,, Wasserscheid J,, Dewar K,, Legare D,, Ouellette M . 2009. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res 19 : 1214– 1223.[PubMed] [CrossRef]
55. Meka VG,, Gold HS . 2004. Antimicrobial resistance to linezolid. Clin Infect Dis 39 : 1010– 1015.[PubMed] [CrossRef]
56. Frere JM . 1995. Beta-lactamases and bacterial resistance to antibiotics. Mol Microbiol 16 : 385– 395.[PubMed] [CrossRef]
57. Wright GD . 2005. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 57 : 1451– 1470.[PubMed] [CrossRef]
58. Ochman H,, Lawrence JG,, Groisman EA . 2000. Lateral gene transfer and the nature of bacterial innovation. Nature 405 : 299– 304.[PubMed] [CrossRef]
59. Andersson DI,, Hughes D . 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8 : 260– 271.[PubMed] [CrossRef]
60. Pukatzki S,, Ma AT,, Sturtevant D,, Krastins B,, Sarracino D,, Nelson WC,, Heidelberg JF,, Mekalanos JJ . 2006. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci USA 103 : 1528– 1533.[PubMed] [CrossRef]
61. Cascales E,, Buchanan SK,, Duche D,, Kleanthous C,, Lloubes R,, Postle K,, Riley M,, Slatin S,, Cavard D . 2007. Colicin biology. Microbiol Mol Biol Rev 71 : 158– 229.[PubMed] [CrossRef]
62. Gagliano VJ,, Hinsdill RD . 1970. Characterization of a Staphylococcus aureus bacteriocin. J Bacteriol 104 : 117– 125.[PubMed]
63. Duche D,, Parker MW,, Gonzalez-Manas JM,, Pattus F,, Baty D . 1994. Uncoupled steps of the colicin A pore formation demonstrated by disulfide bond engineering. J Biol Chem 269 : 6332– 6339.[PubMed]
64. Vankemmelbeke M,, Healy B,, Moore GR,, Kleanthous C,, Penfold CN,, James R . 2005. Rapid detection of colicin E9-induced DNA damage using Escherichia coli cells carrying SOS promoter-lux fusions. J Bacteriol 187 : 4900– 4907.[PubMed] [CrossRef]
65. Boon T . 1972. Inactivation of ribosomes in vitro by colicin E3 and its mechanism of action. Proc Natl Acad Sci USA 69 : 549– 552.[PubMed] [CrossRef]
66. Harkness RE,, Braun V . 1989. Colicin M inhibits peptidoglycan biosynthesis by interfering with lipid carrier recycling. J Biol Chem 264 : 6177– 6182.[PubMed]
67. El Ghachi M,, Bouhss A,, Barreteau H,, Touze T,, Auger G,, Blanot D,, Mengin-Lecreulx D . 2006. Colicin M exerts its bacteriolytic effect via enzymatic degradation of undecaprenyl phosphate-linked peptidoglycan precursors. J Biol Chem 281 : 22761– 22772.[PubMed] [CrossRef]
68. Olschlager T,, Turba A,, Braun V . 1991. Binding of the immunity protein inactivates colicin M. Mol Microbiol 5 : 1105– 1111.[PubMed] [CrossRef]
69. Moss JE,, Cardozo TJ,, Zychlinsky A,, Groisman EA . 1999. The selC-associated SHI-2 pathogenicity island of Shigella flexneri . Mol Microbiol 33 : 74– 83.[PubMed] [CrossRef]
70. Gerard F,, Pradel N,, Wu LF . 2005. Bactericidal activity of colicin V is mediated by an inner membrane protein, SdaC, of Escherichia coli . J Bacteriol 187 : 1945– 1950.[PubMed] [CrossRef]
71. Russell AB,, Peterson SB,, Mougous JD . 2014. Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol 12 : 137– 148.[PubMed] [CrossRef]
72. Suarez G,, Sierra JC,, Erova TE,, Sha J,, Horneman AJ,, Chopra AK . 2010. A type VI secretion system effector protein, VgrG1, from Aeromonas hydrophila that induces host cell toxicity by ADP ribosylation of actin. J Bacteriol 192 : 155– 168.[PubMed] [CrossRef]
73. Russell AB,, Hood RD,, Bui NK,, LeRoux M,, Vollmer W,, Mougous JD . 2011. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475 : 343– 347.[PubMed] [CrossRef]
74. Russell AB,, LeRoux M,, Hathazi K,, Agnello DM,, Ishikawa T,, Wiggins PA,, Wai SN,, Mougous JD . 2013. Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors. Nature 496 : 508– 512.[PubMed] [CrossRef]
75. Koskiniemi S,, Lamoureux JG,, Nikolakakis KC,, t’Kint de Roodenbeke C,, Kaplan MD,, Low DA,, Hayes CS . 2013. Rhs proteins from diverse bacteria mediate intercellular competition. Proc Natl Acad Sci USA 110 : 7032– 7037.[PubMed] [CrossRef]
76. Fritsch MJ,, Trunk K,, Diniz JA,, Guo M,, Trost M,, Coulthurst SJ . 2013. Proteomic identification of novel secreted antibacterial toxins of the Serratia marcescens type VI secretion system. Mol Cell Proteomics 12 : 2735– 2749.[PubMed] [CrossRef]
77. Borgeaud S,, Metzger LC,, Scrignari T,, Blokesch M . 2015. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer. Science 347 : 63– 67.[PubMed] [CrossRef]

Tables

Evolution of Bacterial Pathogens Within the Human Host
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555819286.chap1-1,webId=/content/author/10.1128/9781555819286.chap1-1,properties={foaf_givenname=Kimberly A., foaf_name=Kimberly A. Bliven, foaf_surname=Bliven, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555819286.chap1-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555819286.chap1-2,webId=/content/author/10.1128/9781555819286.chap1-2,properties={foaf_givenname=Anthony T., foaf_name=Anthony T. Maurelli, foaf_surname=Maurelli, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555819286.chap1-aff2]]}]]
Citation: Bliven K, Maurelli A. 2016. Evolution of Bacterial Pathogens Within the Human Host, p 3-13. In Kudva I, Cornick N, Plummer P, Zhang Q, Nicholson T, Bannantine J, Bellaire B (ed),

Virulence Mechanisms of Bacterial Pathogens, Fifth Edition

. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.VMBF-0017-2015
/content/10.1128/9781555819286.chap1.tab1-1
TABLE 1

Examples of pathogenic mechanisms to evade or overcome selective pressures within the human host

Generic image for table
TABLE 1

Examples of pathogenic mechanisms to evade or overcome selective pressures within the human host

Citation: Bliven K, Maurelli A. 2016. Evolution of Bacterial Pathogens Within the Human Host, p 3-13. In Kudva I, Cornick N, Plummer P, Zhang Q, Nicholson T, Bannantine J, Bellaire B (ed),

Virulence Mechanisms of Bacterial Pathogens, Fifth Edition

. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.VMBF-0017-2015

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error